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About 38% of primary HIV-1 long terminal repeats (LTRs) contain an insertion (consensus: 59-ACYGCTGA-39), termed the
most frequent naturally occurring length polymorphism (MFNLP). The MFNLP binds several transcription factors and might
affect HIV-1 replication and disease progression in infected individuals. However, its relevance for proviral transcription and
for HIV-1 replication in primary cells is unclear. We utilized HIV-1 NL4-3 LTR variants to investigate the effect of the MFNLP
on 59LTR transcriptional activity in various cell types. Notably, viral promoter activity was studied in primary cells in the
context of the integrated provirus, using both single cycle assays with pseudotyped Luciferase reporter viruses and
replication-competent HIV-1 mutants. Our results demonstrate that the presence, absence, or duplication of the 59-
ACYGCTGA-39 motif has little effect on viral promoter activity in T cell lines, peripheral blood mononuclear cells (PBMC), and
monocyte-derived macrophages (MDM). Furthermore, all HIV-1 LTR variants showed efficient induction upon stimulation with
TPA and/or ionomycin and replicated with comparable efficiency in a human T cell line and in PBMC. Thus, the MFNLP does
not significantly affect HIV-1 59LTR transcriptional activity and viral replication in primary cells, suggesting that this common
sequence variation has little impact on the clinical course of HIV-1 infection. © 2002 Elsevier Science
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Sequence variations in HIV-1 LTRs might affect the
interaction with cellular factors and alter viral gene ex-
pression in infected cells and the production of progeny
virions. Therefore, natural LTR variations could have an
important impact on the efficiency of viral replication and
the clinical course of HIV-1 infection. The basal and
Tat-induced transcriptional activities vary considerably in
HIV-1-infected individuals, and a variety of deletions and
insertions have been detected in primary LTRs (Connor
et al., 1994; Delassus et al., 1992; Estable et al., 1996;
Gomez-Roman et al., 2000; Kirchhoff et al., 1997; Koken et
al., 1992; Krebs et al., 1998; Michael et al., 1994; Zhang et
al., 1997a). One insertion, termed most frequent naturally
occurring length polymorphism (MFNLP), seems of par-
ticular interest because it is found in approximately 38%
of infected individuals and contains potential binding
sites for a variety of transcription factors, including lym-
phoid enhancer binding factor (hLEF), c-Ets, AP-4, c-Fos,
JunB, and Ras-responsive binding factor 2 (RBF-2) (Ait-
Khaled et al., 1995; Chen et al., 2000; Delassus et al.,
1992; Estabel et al., 1996, 1998; Golub et al., 1990; Go-
mez-Roman et al., 2000; Kirchhoff et al., 1997; Koken et
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169al., 1992; Krebs et al., 1998; Michael et al., 1994; Zhang et
al., 1997a, b). The MFNLP is located between positions
2120 and 2121 in the HIV-1 LTR, just upstream of the
NF-kB binding sites. The length varies between 15 and
34 bp and the insertion contains a highly conserved
59-ACYGCTGA-39 motif. Estable et al. suggested that the
MFNLP binds RBF-2 and represses transcription (Es-
table et al., 1998). Another study showed that the MFNLP
interacts with the AP-1 factors c-Fos and JunB and me-
diates higher inducibility of the LTR by the c-Jun N-
terminal kinase (JNK) signaling pathway (Chen et al.,
2000). The effect of the MFNLP on LTR promoter activity
is controversial and positive (Chen et al., 2000; Golub et
al., 1990), negative (Estable et al., 1998; Koken et al.,
1992; Michael et al., 1994), or no effects (Estable et al.,
1996) have been reported. Some of these discrepancies
might be explained by the use of different cell lines and
stimuli. Furthermore, most LTR variants analyzed in
these studies contained point mutations outside of the
MFNLP region. Notably, most data were obtained in
immortalized cell lines transfected with LTR reporter con-
structs and might not accurately reflect the situation in
HIV-1-infected cells. For example, chromatin organiza-
tion plays a major role in transcriptional regulation of the
integrated provirus (Marzio and Giacca, 1999). Further-
more, expression of many transcription factors is cell-
type dependent and the impact of the MFNLP on tran-
scriptional activity in primary cells, that are also target to
HIV-1 infection in vivo, is currently unclear.
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170 HIEBENTHAL-MILLOW AND KIRCHHOFFWe analyzed the influence of the presence, absence,
or duplication of the 59-ACYGCTGA-39 motif, which is
duplicated by the MFNLP, on proviral transcriptional ac-
tivity and on HIV-1 replication in various cell types. Our
results demonstrate that these LTR variations have little
effect on HIV-1 gene expression and on the inducibility of
the 59LTR. Moreover, all HIV-1 LTR variants showed com-
parable replication kinetics and efficiency. Accordingly,
the MFNLP does not have an important impact on the
transcriptional activity of the proviral HIV-1 genome in
primary T cells or macrophages.
RESULTS
Rationale for mutant construction
We wanted to measure the impact of the MFNLP on
HIV-1 LTR promoter activity in the context of the inte-
grated provirus. Therefore, the mutated LTRs were in-
serted at the 39 end of an env-deleted proviral NL4-3
construct, in which the nef gene was replaced with the
luciferase reporter gene (Fig. 1) (Connor et al., 1995).
Pseudotyped viral particles were generated by cotrans-
FIG. 1. HIV-1 NL4-3 LTR variants analyzed. The proviral NL4-3 repor
indicated by the asterisk and the nef gene is replaced by the luciferase
using the XhoI and EcoRI restriction sites indicated. The deletion in D
box; and the TAR region is indicated. Schematic presentation of the w
of the primary BT94t-B1 LTR, containing a representative MFNLP inse
proviral constructs differed only by the specific changes in the 39LTR.fection of 293T cell with the proviral construct and a
vector expressing the VSV Env protein. Subsequently,these virions were used in a single round of infection
assays. During reverse transcription, the mutated 39 pro-
moter sequences are copied to both the 59 and 39LTRs of
the provirus. Minor effects of the mutations on reverse
transcription and integration cannot be entirely dis-
missed. Nonetheless, this experimental system is highly
useful to readily assess the transcriptional activity of the
HIV-1 59LTR by luciferase assay. As indicated in Fig. 1,
four LTR variants were generated for functional analysis:
(i) NL43(e-n-L1)wt contains the wild-type HIV-1 NL4-3
LTR. (ii) NL43(e-n-L1)mm contains a deletion of 8 bp,
encompassing the putative RBF-2 binding region. This
site is generally duplicated by the MFNLP, and it has
been proposed that the MFNLP is selected in vivo be-
cause it compensates for mutations in this region (Es-
table et al., 1998). (iii) NL43(e-n-L1)pp contains an inser-
tion of 20 bp, which represents a typical MFNLP se-
quence and provides a duplicated RBF-2 cis element. (iv)
Finally, NL43(e-n-L1)mp contains the 20-bp MFNLP but
not the 59 RBF-2 binding site. A representative primary
MFNLP region, derived from patient BT94-B1 (Kirchhoff
et al., 1997), is shown for comparison (Fig. 1). As a
struct carries a frame shift mutation in the env open reading frame as
pper). Mutated LTRs were inserted at the 39 end of the proviral genome
indicated by a black bar; the NF-kB and Sp1 binding sites, the TATA
pp, and mp HIV-1 NL4-3 LTR variants analyzed (lower). The sequence
hen et al., 2000; Kirchhoff et al., 1997) is shown for comparison. The
s indicate sequence identity, and dots indicate deletions.ter con
gene (u
3LTR is
t, mm,negative control, an LTR deletion mutant containing a
deletion of the U3 sequences upstream of the TATA box,
the NL
171RELEVANCE OF THE MFNLP FOR HIV-1 LTR ACTIVITYnamed NL43(e-n-L1)D3LTR, was constructed. This vari-
ant contained an intact 59LTR and all sequences re-
quired for reverse transcription and integration at the 39
end of the proviral genome, but missed the entire en-
hancer and modulatory region (Fig. 1).
The MFNLP has little effect on proviral promoter
activity
HIV-1 particles pseudotyped with the VSV G Env pro-
tein were generated as described (Fouchier et al., 1997),
and A3.01 cells were infected with virus stocks contain-
ing 500 ng of p24 antigen. As shown in Fig. 2A, deletion
of the potential RBF-2 binding site (mm) or insertion of
the MFNLP (pp) had little effect on transcriptional activity
of the NL4-3 LTR. For the NL43(e-n-L1)mp variant, 1.8-
fold-enhanced luciferase activities were obtained. It has
been suggested that the MFNLP region confers higher
inducibility of LTR-luciferase constructs to stimulation by
FIG. 2. Influence of the MFNLP on transcriptional activity. (A) A3.01
protein. (B) Transcriptional activities of the various proviral constucts
Induction factors compared to the activity observed in unstimulated ce
were transduced with pseudotyped HIV-1 particles. Infections were p
experiments with different virus stocks. Promoter activities relative to
infections performed are shown.TPA and Ionomycin (Ion) (Chen et al., 2000). However, we
did not observe marked differences in the levels of acti-vation of A3.01 cells transduced with the various proviral
MFNLP constructs by TPA, Ion, or both (Fig. 2B). Effects
of the MFNLP on transcriptional activity might be cell-
type dependent. Therefore, we next transduced the
monocytic cell line U937 with the same set of HIV-1
NL4-3 LTR variants. In contrast to the results obtained
with the A3.01 cells, the NL43(e-n-L1)mm variant
showed consistently elevated levels of luciferase activity
compared to the NL4-3wt, mp, and pp constructs (Fig.
2C). Similar to the results with the A3.01 cell line, how-
ever, TPA and/or Ion induction of the U937 cells resulted
in comparable levels of induction of all constructs: TPA
(five- to eightfold), Ion (three- to fourfold), and both com-
bined (10–13-fold) (Fig. 2D). Thus, we did not observe the
previously described strong synergistic inducibility of
MFNLP containing LTRs by TPA/Ion in A3.01 cells (Chen
et al., 2000).
Naturally occurring sequence variations in the HIV-1
were transduced with HIV-1 particles pseudotyped with the VSV Env
activation of the A3.01 cells with TPA, Ion, or a combination of both.
given in the lower panel. (C) Uninduced and (D) stimulated U937 cells
ed in triplicate and the results were confirmed in three independent
4-3 wt LTR (100%) together with standard errors obtained for all ninecells
upon
lls are
erformLTR might predominantly play a role in primary cells that
are also target to viral infection in infected individuals.
ing 500
172 HIEBENTHAL-MILLOW AND KIRCHHOFFTherefore, we next investigated the effect of the MFNLP
on transcriptional activity in transduced primary PBMC
and macrophages. Our data show that the insertion of
the MFNLP (pp), deletion of the potential RBF-2 binding
site (mm), or both (mp) did not significantly alter the
transcriptional activity in both PBMC and MDM (Fig. 3).
Impact of the MFNLP on HIV-1 replication
The results obtained using the single round of infec-
tion assays demonstrated that the MFNLP does not have
major effects on transcriptional activity of the HIV-1 pro-
virus in T cells and macrophages. However, subtle dif-
ferences in promoter activity might be amplified and
become more obvious over multiple rounds of infection.
Therefore, we reconstituted the intact env gene of the
X4-tropic NL4-3 clone for the generation of replication-
competent HIV-1 LTR variants. Some deletions in the
39LTR of the proviral NL43 constructs alter the predicted
C-terminal amino acid sequence of the Nef protein,
which might affect viral replication in primary cells (Miller
et al., 1994; Spina et al., 1994). Therefore, we utilized a
nef-deleted background to exclude the possibility that
differences in Nef function could bias the results.
All HIV-1 MFNLP variants replicated with replication
kinetics similar to the parental NL4-3 clone in A3.01 cells
(Fig. 4), and in prestimulated PBMC (Fig. 5A). The D3LTR
variant was inactive, indicating that no recombination of
the deleted 39LTR region with the intact 59LTR se-
quences that restored functional activity occurred. Pre-
vious findings suggest that the MFNLP might increase
the responsiveness of the LTR toward stimulation (Chen
et al., 2000). To follow up on this observation, we infected
PBMC immediately after isolation and activated them by
various stimuli 3 days later. The results varied slightly
between different experiments. However, some differ-
ences in the replicative capacity were consistently ob-
served under these experimental conditions. Following
PHA stimulation the NL43(n2)mm LTR variant produced
the highest amounts of virus, followed by the
NL43(n2)mp mutant. The NL43(n2)pp variant containing
FIG. 3. Promoter activity of HIV-1 NL4-3 variants in primary cells. Hu
and transduced in triplicate with pseudotyped viral particles contain
experiments using cells derived from different donors.the MFNLP replicated with an efficiency indistinguish-
able from NL4-3 wild type (Fig. 5B). Stimulation withOKT3a yielded similar results, except that the parental
NL4-3 clone replicated with slightly higher efficiency (Fig.
5C). With TPA, the NL43(n2)mp showed accelerated
levels of replication (Fig. 5D). The remaining variants
replicated with kinetics similar to NL4-3 wild type. Unex-
pectedly, all variants replicated less efficiently than the
parental NL4-3 clone after stimulation with Ion (Fig. 5E).
Overall the levels of viral replication were low after co-
stimulation with both TPA and Ion (Fig. 5F). Under these
experimental conditions, the NL43(n2)mp virus repli-
cated less efficienty than the forms that did not contain
the duplication.
DISCUSSION
The data generated in the present study demonstrate
that the MFNLP region does not have a significant effect
on HIV-1 promoter activity or replication. Unlike previous
studies that suggested various effects of the MFNLP on
transcription (Chen et al., 2000; Estable et al., 1996, 1998;
Koken et al., 1992; Golub et al., 1990; Michael et al., 1994),
we investigated the effect of the MFNLP in primary T
cells and macrophages in the context of the integrated
MC (left) and MDM (right) were isolated as described in the methods
ng p24 antigen. Similar results were obtained in four independent
FIG. 4. The MFNLP does not affect HIV-1 replication in A3.01 cells.
The cells were infected with virus stocks containing 100 ng of p24
antigen and viral replication was determined by reverse transcriptase
assay. Shown are the results of one representative experiment. Abbre-




173RELEVANCE OF THE MFNLP FOR HIV-1 LTR ACTIVITYprovirus. Consistent with the finding that the presence of
the MFNLP is not associated with the clinical stage of
HIV-1-infection or with disease progression rates (Es-
table et al., 1996), our findings indicate that the MFNLP
does not have an important impact on HIV-1 replication
both in vitro and in vivo.
Chen et al. have provided evidence that the MFNLP
confers higher inducibility upon stimulation (Chen et al.,
2000). They demonstrated that a natural LTR containing
the MFNLP shows synergistic effects upon TPA/ion dou-
ble stimulation. Unexpectedly, we found that all proviral
LTR variants showed comparable responsiveness to-
ward stimulation by TPA and/or Ion. Thus, in the context
of the integrated provirus, the MFNLP did not show
synergistic transcriptional activation upon double stimu-
lation. In both studies the same T cell line (A3.01) and
comparable concentrations of stimulatory agents were
used. Nonetheless, differences in the experimental set-
tings could explain the discrepant results. Coexpression
of other viral proteins could affect the transcriptional
activity. The natural MFNLP-containing LTR analyzed in
the previous study contained some additional mutations
in the LTR, whereas our proviral constructs differed only
in the MFNLP region. Possibly, LTR reporter constructs
might represent a more sensitive system to monitor pro-
moter responsiveness. However, utilization of proviral
constructs more closely mimics the situation in infected
target cells and is presumably more relevant for HIV-1
FIG. 5. Replication of HIV-1 NL4-3 MFNLP variants in PBMC. Cells
immediately after isolation and treated with the indicated agents 3 days
The cells were stimulated and viral replication was measured as d
independent experiments. Symbols are indicated in the legend to Fig.infection in vivo.
If the MFNLP does not significantly affect HIV-1 pro-moter activity, why does it occur in a significant number
of primary LTRs? Estable et al. have suggested that the
MFNLP is selected because it provides a duplicated
RBF-2 binding element which inhibits transcription in
RBF-2 expressing monocytes and activated T cells (Es-
table et al., 1998). However, the repressive effects of the
MFNLP were subtle and the authors suggested that the
effects might be more significant in the context of chro-
matin. Notably, we found that the MFNLP slightly re-
duced and that the deletion of both RBF-2 binding sites
enhanced the transcriptional activity of the NL4-3 LTR in
U937 cells, which express RBF-2 (Estable et al., 1998).
However, these effects were minor and the MFNLP did not
attenuate viral replication in PBMC. It remains possible that
the MFNLP plays a more relevant role in some yet-to-be-
defined primary cell types, particularly under conditions
when specific MFNLP-binding factors which repress LTR
transcription, like RBF-2 (Estable et al., 1998), or have stim-
ulatory effects, like the AP-1 factors c-Fos and JunB (Chen
et al., 2000), are strongly activated. However, such putative
functions of the MFNLP presumably play only a minor role
in the clinical course of HIV-1 infection. It has become clear
that even highly conserved LTR elements have limited rel-
evance for viral pathogenicity. For example, deletion of the
NF-kB and Sp1 binding sites in the LTR of simian immuno-
deficiency virus does not attenuate viral replication and
AIDS progression in vivo in infected rhesus macaques
(Ilyinskii et al., 1997).
ither prestimulated with PHA for 3 days prior to infection or infected
Infections were performed with virus containing 100 ng of p24 antigen.
ed in the Methods section. The results were confirmed in severalwere e
later.One pathogenic HIV-1 isolate lacking intact NF-kB
binding sites but containing the MFNLP has been de-
174 HIEBENTHAL-MILLOW AND KIRCHHOFFscribed (Zhang et al., 1997a). Thus, one function of the
MFNLP in vivo could be to compensate for the loss of
core enhancer elements. However, it remained unclear if
the presence of the MFNLP did in fact functionally com-
pensate for the loss of NF-kB binding sites or was coin-
cidential. Furthermore, such deletions are very rare in
HIV-1 infection. We analyzed LTRs derived from 210 HIV-
1-infected individuals and found that intact NF-kB and
Sp1 binding sites were generally (100%) present (data
not shown). Thus, it is questionable whether compensa-
tion for deletions elsewhere in the viral LTR is the selec-
tive force that drives the selection for the MFNLP.
The proviral constructs utilized in our study did not ex-
press the accessory nef gene, which is an important viru-
lence factor (Kestler et al., 1991). The nef gene was inacti-
vated because replacement with the luciferase reporter
gene provides a highly sensitive and convenient system to
measure proviral transcriptional activity and because some
of the LTR mutations analyzed would also change the
C-terminal sequence of Nef. Thus, altered Nef function
could bias the results on the relevance of the MFNLP for
LTR activity. It has been shown recently that Nef induces a
broad variety of transcriptions factors (Simmons et al.,
2001), some of which could interact with the MFNLP and
alter transcriptional activity. However, the transcriptional
program induced by Nef in T cells was 97% identical to that
of anti-CD3 T cell activation (Simmons et al., 2001). We did
not observe a marked effect of the MFNLP on viral replica-
tion in PBMC that were stimulated using the OKT3a anti-
CD3 antibody. Thus, most likely comparable results would
be obtained in presence of Nef.
In conclusion, the MFNLP seems not to play an im-
portant role for HIV-1 promoter activity in infected pri-
mary cells. Forms containing the MFNLP likely occur
frequently through template switching or RT slippage
during reverse transcription (Estable et al., 1998). The
presence or absence of these duplications might not
result in a significant advantage or disadvantage for viral
replication in vivo. This assumption would explain why
the MFNLP is present in a high number of HIV-1-infected
individuals, but does not correlate with disease progres-
sion rates, levels of viral replication, or the clinical stage
of infection (Estable et al., 1996).
MATERIAL AND METHODS
Mutant construction
Mutagenesis was performed by splice overlap exten-
sion PCR (Ho et al., 1989), using mutagenic internal
primers that introduced the sequence variations shown
in Fig. 1 into the 39 end of the env defective proviral
pNL4-3.Luc.R2E2 clone (Connor et al., 1995), which ex-
presses the luciferase reporter gene. An otherwise iso-
genic construct missing the 39LTR U3 sequences up-
stream of the TATA box, corresponding to nucleotides
8793 to 9498 in the published HIV-1 NL4-3 sequence,named NL43(e-n-L1)D3LTR, served as negative control.
Replication-competent virus was generated by inserting
the modified 39LTR sequences into an HIV-1 NL4-3 pro-
virus containing an intact env gene (Carl et al., 2000)
using standard cloning techniques. All PCR-derived in-
serts were sequenced to confirm that only the intended
changes were present.
Virus stocks
Generation of virus stocks was performed by the calcium
phosphate method (Cullen, 1987). Briefly, for the generation
of pseudotyped viral particles, 293T cells were cotrans-
fected with 6 mg of NL43(e-n-L1) and 3 mg of a plasmid
(pHIT-G) expressing the Env protein of the vesicular stoma-
titis virus (VSV G) (Fouchier et al., 1997). For the production
of replication-competent virus, 293T cells were transfected
with 10 mg of the nef-deleted full-length NL4-3 proviral
constructs. Viral stocks were aliquoted and frozen at
280°C. The p24 antigen concentrations were quantitated
by using an HIV–ELISA provided by the NIH AIDS Research
and Reference Reagent Program.
Cell culture
293T cells were maintained in DMEM supplemented
with 10% FCS. A3.01 and U937 cells were maintained in
1640 RPMI 1640 with 10% FCS. PBMC were isolated
using lymphocyte separation medium (Biochrom KG,
Germany), stimulated 3 days with 4 mg/ml phytohemag-
glutinin (PHA) and cultured in RPMI 1640 medium with
20% FCS and 50 U interleukin-2 (IL-2) per milliliter. Alter-
natively, PBMC were stimulated using an anti-Okt3a an-
tibody, 10 ng/ml 12-tetradecanoate 13-acetate (TPA), 0.5
mM Ion, or TPA plus Ion (purchased from Sigma, St.
Louis, MO). For monocyte-derived macrophage (MDM)
isolation, cells were isolated from fresh blood as de-
scribed above. Cells (7.5 3 105) were seeded in 48-well
dishes and cultured for 1 week in RPMI1640 supple-
mented with 10% human serum (GibcoBRL, Carlsbad,
CA), 50 U/ml GM-CSF (Boehringer Mannheim, Germany),
and antibiotics to allow monocyte differentiation and
adherence to the plates. Subsequently, nonadherent
cells were removed by extensive washing with PBS. All
cells were cultured at 37°C and 5% CO2.
Reporter assays
A3.01 and U937 cells were seeded at 1 3 105 in
24-well dishes and PBMC at 1 3 106 in 48-well dishes
and transduced with aliquots of virus stocks containing
500 ng p24 antigen in a total volume of 250 or 150 ml
medium, respectively. At 4 h after transduction, medium
was added to a final volume of 1 ml or 500 ml, respec-
tively. At 3 or 4 days after infection the cells were pel-
leted, washed once with phosphate-buffered saline, and
resuspended in 50 ml lysis buffer (Promega, Madison,
WI). Cell debris was removed by centrifugation and 5 ml
175RELEVANCE OF THE MFNLP FOR HIV-1 LTR ACTIVITYof the supernatant was used to determine the total pro-
tein concentration with a commercial reagent (Bio-Rad
Laboratories, Hercules, CA). Luciferase assays were
performed with the Promega assay system as recom-
mended by the manufacturer. Induction with TPA (10
ng/ml) or Ion (0.5 mM) was performed 16 h prior to
harvesting.
Viral replication
Infections were always performed with aliquots of viral
stocks containing 100 ng p24 antigen or pseudotyped
viral particles containing 500 ng p24 antigen. Cell culture
supernatants were sampled at regular intervals and
stored at 220°C. Virus production was measured by a
“mini” reverse transcriptase assay in 96-well plates as
described elsewhere (Potts, 1990).
ACKNOWLEDGMENTS
A number of reagents were obtained through the NIH AIDS Research
and Reference Program, Division of AIDS, NIAID, NIH. We thank Mandy
Krumbiegel and Nathaly Finze for excellent technical assistance and
Peifeng Chen and Egbert Flory for helpful comments. We are also
grateful to Bernhard Fleckenstein and Ralf Grassmann for support and
Nathaniel R. Landau for the NL4-3-LucR2E2 clone. This work was
supported by the Deutsche Forschungsgemeinschaft.
REFERENCES
Ait-Khaled, M. J., McLaughlin, E., Johnson, M. A., and Emery, V. C. (1995).
Distinct HIV-1 long terminal repeat quasispecies present in nervous
tissues compared to that in lung, blood and lymphoid tissues of an
AIDS patient. AIDS 9, 675–683.
Carl, S., Daniels, R., Iafrate, A. J., Easterbrook, P., Greenough, T. C.,
Skowronski, J., and Kirchhoff, F. (2000). Partial “repair” of defective
NEF genes in a long-term nonprogressor with human immunodefi-
ciency virus type 1 infection. J. Infect. Dis. 181, 132–140.
Chen, P., Flory, E., Avots, A., Jordan, B. W., Kirchhoff, F., Ludwig, S., and
Rapp, U. R. (2000). Transactivation of naturally occurring HIV-1 long
terminal repeats by the JNK signaling pathway. J. Biol. Chem. 275,
20381–20390.
Connor, R. I., and Ho, D. D. (1994). Human immunodeficiency virus type
1 variants with increased replicative capacity develop during the
asymptomatic stage before disease progression. J. Virol. 68, 4400–
4408.
Connor, R. I., Chen, B. K., Choe, S., and Landau, N. R. (1995). Vpr is
required for efficient replication of HIV-1 in mononuclear phagocytes.
Virology 206, 935–944, doi:10.1006/viro.1995.1016.
Cullen, B. R. (1987). Use of eukaryotic expression technology in the
functional analysis of cloned genes. Methods Emzmol. 152, 684–703.
Delassus, S., Cheynier, R., and Wain-Hobson, S. (1992). Evolution of
human immunodeficiency virus type 1 nef and long terminal repeat
sequences over 4 years in vivo and in vitro. J. Virol. 65, 225–231.
Estable, M. C., Bell, B., Merzouki, A., Montaner, J. S., O’Shaughnessy,
M. V., and Sadowski, I. J. (1996). Human immunodeficiency virus type
1 long terminal repeat variants from 42 patients representing all
stages of infection display a wide range of sequence polymorphism
and transcription activity. J. Virol. 70, 4053–4062.
Estable, M. C., Bell, B., Hirst, M., and Sadowski, I. (1998). Naturally
occurring human immunodeficiency virus type 1 long terminal re-
peats have a frequently observed duplication that binds RBF-2 and
represses transcription. J. Virol. 72, 6465–6474.Fouchier, R. A., Meyer, B. E., Simon, J. H., Fischer, U., and Malim, M. H.
(1997). HIV-1 infection of non-dividing cells: Evidence that the amino-
terminal basic region of the viral matrix protein is important for Gag
processing but not for post-entry nuclear import. EMBO J. 16, 4531–
4539.
Golub, E. I., Li, G. G., and Volsky, D. J. (1990). Differences in the basal
activity of the long terminal repeat determine different replicative
capacities of two closely related human immunodeficiency virus type
1 isolates. J. Virol. 64, 3654–3660.
Gomez-Roman, V. R., Vazquez, J. A., del Carmen Basualdo, M., Estrada,
F. J., Ramos-Kuri, M., and Soler, C. (2000). nef/long terminal repeat
quasispecies from HIV type 1-infected Mexican patients with differ-
ent progression patterns and their pathogenesis in hu-PBL-SCID
mice. AIDS Res. Hum. Retroviruses 16, 441–452.
Ho, S. N., Hunt, H. D., Horton, R. M., Pullen, J. K., and Pease, L. R. (1998).
Site directed mutagenesis by overlap extension using the polymer-
ase chain reaction. Gene 77, 51–59.
Ilyinskii, P. O., Simon, M. A., Czajak, S. C., Lackner, A. A., and Desro-
siers, R. C. (1997). Induction of AIDS by Simian immunodeficiency
virus lacking NF-B and Sp1 binding elements. J. Virol. 71, 1880–1887.
Kestler, H. W., Ringler, D. J., Mori, K., Panicali, D. L., Sehgal, P. K., Daniel,
M. D., and Desrosiers, R. C. (1991). Importance of the nef gene for
maintenance of high virus loads and for development of AIDS. Cell
65, 651–662.
Kirchhoff, F., Greenough, T. C., Hamacher, M., Sullivan, J. L., and Des-
rosiers, R. C. (1997). Activity of human immunodeficiency virus type 1
promoter/TAR regions and tat1 genes derived from individuals with
different rates of disease progression. Virology 232, 319–331, doi:
10.1006/viro.1997.8586.
Koken, S. E., van Wamel, J. L., Goudsmit, J., Berkhout, B., and Geelen,
J. L. (1992). Natural variants of the HIV-1 long terminal repeat: Anal-
ysis of promoters with duplicated DNA regulatory motifs. Virology
191, 968–972.
Krebs, F. C., Mehrens, D., Pomeroy, S., Goodenow, M. M., and Wigdahl,
B. (1998). Human immunodeficiency virus type 1 long terminal repeat
quasispecies differ in basal transcription and nuclear factor recruit-
ment in human glial cells and lymphocytes. J. Biomed. Sci. 5, 31–44.
Marzio, G., and Giacca, M. (1999). Chromatin control of HIV-1 gene
expression. Genetica 106, 125–130.
Michael, N. L., D’Arcy, L., Ehrenberg, P. K., and Redfield, R. R. (1994).
Naturally occurring genotypes of the human immunodeficiency virus
type 1 long terminal repeat display a wide range of basal and
Tat-induced transcriptional activities. J. Virol. 68, 3163–3174.
Miller, M. D., Warmerdam, M. T., Gaston, I., Greene, W. C., and Feinberg,
M. B. (1994). The human immunodeficiency virus-1 nef gene product:
A positive factor for viral infection and replication in primary lympho-
cytes and macrophages. J. Exp. Med. 179, 101–114.
Potts, B. J. (1990). “Mini” reverse transcriptase (RT) assay. In “Tech-
niques in HIV Research” (A. Aldovini and B. D. Walker, Eds.), pp.
103–106, Stockton, New York.
Simmons, A., Aluvihare, V., and McMichael, A. (2001). Nef triggers a
transcriptional program in T cells imitating single-signal T cell acti-
vation and inducing HIV virulence mediators. Immunity 14, 763–777.
Spina, C. A., Kwoh, T. J., Chowers, M. Y., Guatelli, J. C., and Richman,
D. D. (1994). The importance of nef in the induction of human
immunodeficiency virus type 1 replication from primary quiescent
CD4 lymphocytes. J. Exp. Med. 179, 115–123.
Zhang, L. Y., Huang, H., Yuan, B. K., Chen, J. I., and Ho, D. D. (1997a).
Identification of a replication-competent pathogenic human immuno-
deficiency virus type 1 with a duplication in the TCF-region but
lacking NF-B binding sites. J. Virol. 71, 1651–1656.
Zhang, L., Huang, Y., Yuan, H., Chen, B. K., Ip, J., and Ho, D. D. (1997b).
Genotypic and phenotypic characterization of long terminal repeat
sequences from long-term survivors of human immunodeficiency
virus type 1 infection. J. Virol. 71, 5608–5613.
